Ashley E. Shay

Ashley E. Shay

Auto-generated profile, based on publicly available information

Ashley E. Shay

The Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ASAshley E. Shay
Ashley E. Shay
RNRobert Nshimiyimana
Robert Nshimiyimana
BSBengt Samuelsson
Bengt Samuelsson
NPNicos A. Petasis
Nicos A. Petasis
JHJesper Z. Haeggström
Jesper Z. Haeggström
CSCharles Serhan
Charles Serhan
Significance: The resolution of the acute inflammatory response is an active, highly organized process essential for tissue regeneration, wound healing, and the return to homeostasis that involves specialized proresolving mediators (SPMs). The elucidation of mediators that play roles in these processes is of general interest since many widely occurring diseases display unresolved inflammation in their pathobiology. Here, we document the pivotal role of 4 S ,5 S -epoxy-resolvin as an intermediate in the biosynthesis of resolvin D3 and resolvin D4 and identified a unique cysteinyl-resolvin isomer that is biosynthesized in a cell type–specific manner. Results from cell- and model organism–based systems each defined the potent bioactivity of the cysteinyl-resolvin isomer.

5 October 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CJCharlotte C. Jouvene
Charlotte C. Jouvene
ASAshley E. Shay
Ashley E. Shay
MSMieke A. Soens
Mieke A. Soens
PNPaul C. Norris
Paul C. Norris
JHJesper Z. Haeggström
Jesper Z. Haeggström
CSCharles Serhan
Charles Serhan
Resolution of inflammation is an active process regulated by specialized proresolving mediators where we identified 3 new pathways producing allylic epoxide‐derived mediators that stimulate regeneration [ i.e. , peptido‐conjugates in tissue regeneration (CTRs)]. Here, using self‐limited Escherichia coli peritonitis in mice, we identified endogenous maresin (MaR) CTR (MCTR), protectin (PD) CTR (PCTR), and resolvin CTR in infectious peritoneal exudates and distal spleens, as well as investigated enzymes involved in their biosynthesis. PCTRs were identified to be temporally regulated in peritoneal exudates and spleens. PCTR1 and MCTR1 were each produced by human recombinant leukotriene (LT) C 4 synthase (LTC 4 S) and glutathione S‐transferases (GSTs) [microsomal GST (mGST)2, mGST3, and GST‐μ (GSTM)4] from their epoxide precursors [16 S ,17 S ‐epoxy‐PD (ePD) and 13 S ,14 S ‐epoxy‐MaR (eMaR)], with preference for GSTM4. Both eMaR and ePD inhibited LTB4 production by LTA 4 hydrolase. LTC 4 S, mGST2, mGST3, and GSTM4 were each expressed in human M1‐ and M2‐like macrophages where LTC 4 S inhibition increased CTRs. Finally, PCTR1 showed potent analgesic action. These results demonstrate CTR biosynthesis in mouse peritonitis, human spleens, and human macrophages, as well as identification of key enzymes in these pathways. Moreover, targeting LTC 4 S increases CTR metabolomes, giving a new strategy to stimulate resolution and tissue regeneration.—Jouvene, C. C., Shay, A. E., Soens, M. A., Norris, P. C., Haeggström, J. Z., Serhan, C. N. Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents. FASEB J. 33, 13794‐13807 (2019). www.fasebj.org

6 March 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
BSBrian E. Sansbury
Brian E. Sansbury
XLXiaofeng Li
Xiaofeng Li
BWBlenda Wong
Blenda Wong
CRColin O. Riley
Colin O. Riley
ASAshley E. Shay
Ashley E. Shay
MSMatthew Spite
Matthew Spite

16 July 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
KHKajal Hamidzadeh
Kajal Hamidzadeh
JWJodi Westcott
Jodi Westcott
NWNicholas Wourms
Nicholas Wourms
ASAshley E. Shay
Ashley E. Shay
APAnand Panigrahy
Anand Panigrahy
CSCharles Serhan
Charles Serhan

5 April 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
LNLance G.A. Nunes
Lance G.A. Nunes
CMChi Ma
Chi Ma
FHFuKun W. Hoffmann
FuKun W. Hoffmann
ASAshley E. Shay
Ashley E. Shay
MPM.w. Pitts
M.w. Pitts
PHPeter R. Hoffmann
Peter R. Hoffmann
Selenoprotein I (SELENOI) catalyzes the final reaction of the CDP-ethanolamine branch of the Kennedy pathway, generating the phospholipids phosphatidylethanolamine (PE) and plasmenyl-PE. Plasmenyl-PE is a key component of myelin and is characterized by a vinyl ether bond that preferentially reacts with oxidants, thus serves as a sacrificial antioxidant. In humans, multiple loss-of-function mutations in genes affecting plasmenyl-PE metabolism have been implicated in hereditary spastic paraplegia, including SELENOI. Herein, we developed a mouse model of nervous system-restricted SELENOI deficiency that circumvents embryonic lethality caused by constitutive deletion and recapitulates phenotypic features of hereditary spastic paraplegia. Resulting mice exhibited pronounced alterations in brain lipid composition, which coincided with motor deficits and neuropathology including hypomyelination, elevated reactive gliosis, and microcephaly. Further studies revealed increased lipid peroxidation in oligodendrocyte lineage cells and disrupted oligodendrocyte maturation both in vivo and in vitro. Altogether, these findings detail a critical role for SELENOI-derived plasmenyl-PE in myelination that is of paramount importance for neurodevelopment.

15 April 2022 in Journal of Dental Research
Verified
Journal Article
Closed access
ARA. Rakian
A. Rakian
RRR. Rakian
R. Rakian
ASA.E. Shay
A.E. Shay
CSC.N. Serhan
C.N. Serhan
TDThomas Van Dyke
Thomas Van Dyke
Periodontal disease is a significant public health problem worldwide. Excess unresolved chronic inflammation destroys the periodontal tissues that surround and support the teeth, and efforts to control inflammation by removal of bacterial deposits on the teeth have limited long-term impact. Likewise, procedures aimed at regeneration of the periodontal tissues have shown limited success. Recent advances in stem cell research have shown promising novel prospects for the use of periodontal ligament stem cells (PDLSCs) in tissue regeneration; however, control of inflammation remains a barrier. Human PDLSCs have been shown to release specialized proresolving lipid mediators (SPMs) that modulate the immune response and promote resolution of inflammation, tissue repair, and regeneration. Studies on stem cell biology in periodontology have also been limited by the lack of a good large animal model. Herein, we describe PDLSC biology of the Yorkshire pig (pPDLSCs). pPDLSCs were isolated and characterized. Using lipid mediator profiling, we demonstrate for the first time that pPDLSCs biosynthesize cysteinyl-containing SPMs (cys-SPMs), specifically, maresin conjugates in tissue regeneration 3 (MCTR3) and its authentication using liquid chromatography/tandem mass spectrometry. The exogenous addition of the n-3 precursor docosahexaenoic acid enhances MCTR3 biosynthesis. Using immunocytochemistry, we show that pPDLSCs express 4 of the SPM biosynthetic pathway enzymes necessary for SPM biosynthesis, including 5-lipoxygenase, 12-lipoxygenase, and 15-lipoxygenase-1. In addition, we identified and quantified the cytokine/chemokine profile of pPDLSCs using a 13-plex immunology multiplex assay and found that the pretreatment of pPDLSCs with MCTR3 in an inflammatory environment reduced the production of acute and chronic proinflammatory cytokines/chemokines. Together, these results suggest that enhancing resolution of inflammation pathways and mediators may be a possible key early event in predictable periodontal regeneration.